Literature DB >> 14712484

Differential regulation of VEGF, HIF1alpha and angiopoietin-1, -2 and -4 by hypoxia and ionizing radiation in human glioblastoma.

Eva L Lund1, Anja Høg, Minna W B Olsen, Lasse T Hansen, Svend A Engelholm, Paul E G Kristjansen.   

Abstract

We examined how ionizing radiation (IR) delivered under either severe hypoxia (< 0.1% O2) or normoxia affects the expression of hypoxia inducible factor 1alpha (HIF-1alpha) and the angiogenic factors vascular endothelial growth factor (VEGF) and angiopoietins 1, 2 and 4 in U87 human glioblastoma cells. IR was delivered as single doses of 0, 2, 5, 10 and 20 Gy after 6-hr hypoxic incubation and in normoxic controls. Irradiation at any dose did not affect the cellular protein levels of any of the angiopoietins, whereas hypoxia led to increasing levels of both angiopoietin-4 and angiopoietin-2. Levels of angiopoietin-1 protein were unaltered throughout the observation period. A dose-dependent increase in levels of secreted VEGF in the medium occurred after IR at doses from 5-20 Gy. In hypoxic cells, 20 Gy IR induced an additional significant increase in VEGF relative to nonirradiated hypoxic control cells with elevated baseline VEGF levels induced by hypoxia. HIF-1alpha and glucose transporter-1 (Glut-1) were not correspondingly upregulated by IR. Blocking HIF-1alpha by antisense treatment induced a reduced baseline VEGF at normoxia, while the relative upregulation of VEGF by IR was unaffected. These data provide evidence that VEGF is upregulated by IR by mechanisms independent of HIF-1 transactivation. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14712484     DOI: 10.1002/ijc.11662

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  22 in total

1.  Pro-apoptotic and anti-angiogenic properties of the α /β-thujone fraction from Thuja occidentalis on glioblastoma cells.

Authors:  Angelo Torres; Yosselyn Vargas; Daniel Uribe; Cristian Carrasco; Cristian Torres; René Rocha; Carlos Oyarzún; Rody San Martín; Claudia Quezada
Journal:  J Neurooncol       Date:  2016-02-22       Impact factor: 4.130

2.  The addition of Sunitinib to radiation delays tumor growth in a murine model of glioblastoma.

Authors:  Randy D'Amico; Liang Lei; Benjamin C Kennedy; Julia Sisti; Victoria Ebiana; Celina Crisman; James G Christensen; Orlando Gil; Steven S Rosenfeld; Peter Canoll; Jeffrey N Bruce
Journal:  Neurol Res       Date:  2012-03-05       Impact factor: 2.448

3.  Angiopoietin-4 increases permeability of blood vessels and promotes lymphatic dilation.

Authors:  Cristina T Kesler; Ethel R Pereira; Cheryl H Cui; Gregory M Nelson; David J Masuck; James W Baish; Timothy P Padera
Journal:  FASEB J       Date:  2015-05-14       Impact factor: 5.191

4.  A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patients.

Authors:  J J Raizer; P Giglio; J Hu; M Groves; R Merrell; C Conrad; S Phuphanich; V K Puduvalli; M Loghin; N Paleologos; Y Yuan; D Liu; A Rademaker; W K Yung; B Vaillant; J Rudnick; M Chamberlain; N Vick; S Grimm; I W Tremont-Lukats; J De Groot; K Aldape; M R Gilbert
Journal:  J Neurooncol       Date:  2016-01       Impact factor: 4.130

Review 5.  Imaging hypoxia in gliomas.

Authors:  I Mendichovszky; A Jackson
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

6.  Hypoxia inducible factor 1-alpha regulates of platelet derived growth factor-B in human glioblastoma cells.

Authors:  Daizo Yoshida; Kyongson Kim; Masahiro Noha; Akira Teramoto
Journal:  J Neurooncol       Date:  2005-07-30       Impact factor: 4.130

7.  Effects of irradiation on brain vasculature using an in situ tumor model.

Authors:  Janice A Zawaski; M Waleed Gaber; Omaima M Sabek; Christy M Wilson; Christopher D Duntsch; Thomas E Merchant
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-12-22       Impact factor: 7.038

Review 8.  Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target.

Authors:  Randy L Jensen
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

Review 9.  Use of FDA approved methamphetamine to allow adjunctive use of methylnaltrexone to mediate core anti-growth factor signaling effects in glioblastoma.

Authors:  R E Kast
Journal:  J Neurooncol       Date:  2009-03-26       Impact factor: 4.130

10.  In vitro angiogenesis by human umbilical vein endothelial cells (HUVEC) induced by three-dimensional co-culture with glioblastoma cells.

Authors:  Zhijian Chen; Andre Htay; Wagner Dos Santos; George T Gillies; Helen L Fillmore; Milton M Sholley; William C Broaddus
Journal:  J Neurooncol       Date:  2008-11-28       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.